{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:16:10Z","timestamp":1793726170780,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31971068"],"award-info":[{"award-number":["31971068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31971068"],"award-info":[{"award-number":["31971068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31971068"],"award-info":[{"award-number":["31971068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31971068"],"award-info":[{"award-number":["31971068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is the most common endocrinopathy associated with infertility and metabolic disorder in women of reproductive age. Animal models have been developed and used as tools to unravel the pathogenesis of PCOS, among which most postnatal models employ continuing experimental manipulations. However, the persistence and stability of these animals after modeling is unknown. Dehydroepiandrosterone (DHEA)-induced PCOS mouse model is commonly used in PCOS studies. Thus the aim of the present study was to investigate the reproductive features of DHEA-induced PCOS mice fed a normal chow or an high-fat diet (HFD) with treatment withdrawal or consecutive treatments after PCOS mouse models were established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prepubertal C57BL\/6\u00a0J mice (age 25\u00a0days) were injected (s.c.) daily with DHEA on a normal chow or a 60% HFD for 20 consecutive days to induce PCOS mouse models. Mice injected with the vehicle sesame oil were used as controls. After 20\u00a0days, mice were divided into 2 groups, namely \u201cContinue dosing group\u201d and \u201cStop dosing group\u201d. The animals were consecutively treated with DHEA or DHEA\u2009+\u2009HFD, or housed without any treatment for 2 or 4\u00a0weeks. Estrous cycles were evaluated during this period. At the end of the experiment, serum testosterone (T) levels were measured and the morphology of ovaries was evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mice in Continue dosing groups maintained reproductive phenotypes of PCOS mouse models. In contrast, 2 or 4\u00a0weeks after PCOS models were established, the mice with treatment withdrawal in Stop dosing groups exhibited normal serum testosterone levels, regular estrous cycle, and relatively normal ovarian morphology. In addition, even with consecutive treatments, there was no marked difference in body weight between DHEA mice on the normal chow or an HFD in Continue dosing groups and the control animals 3\u00a0weeks after modeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>After PCOS mice were induced with DHEA or DHEA\u2009+\u2009HFD, the mice still need consecutive treatments to maintain reproductive phenotypes to be regarded as PCOS mice that meet the diagnostic criteria of PCOS defined by the 2003 Rotterdam criteria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13048-023-01299-8","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T04:02:19Z","timestamp":1698206539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes"],"prefix":"10.1186","volume":"16","author":[{"given":"Haowen","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bining","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,25]]},"reference":[{"issue":"4","key":"1299_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219\u201331.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"1299_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137.","journal-title":"Hum Reprod"},{"issue":"1","key":"1299_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1741-7015-8-41","volume":"8","author":"H Teede","year":"2010","unstructured":"Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8(1):41.","journal-title":"BMC Med"},{"issue":"1","key":"1299_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMcp1514916","volume":"375","author":"CR McCartney","year":"2016","unstructured":"McCartney CR, Marshall JC. Polycystic Ovary Syndrome. Solomon CG, ed. N Engl J Med. 2016;375(1):54\u201364.","journal-title":"N Engl J Med"},{"issue":"4","key":"1299_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/humupd\/dmp008","volume":"15","author":"L Moran","year":"2009","unstructured":"Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update. 2009;15(4):477\u201388.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"1299_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1210\/endrev\/bnac001","volume":"43","author":"M Dapas","year":"2022","unstructured":"Dapas M, Dunaif A. Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification. Endocr Rev. 2022;43(6):927\u201365.","journal-title":"Endocr Rev"},{"key":"1299_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S37559","volume":"6","author":"SM Sirmans","year":"2013","unstructured":"Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6:1\u201313.","journal-title":"Clin Epidemiol"},{"issue":"12","key":"1299_CR8","doi-asserted-by":"publisher","first-page":"bqac164","DOI":"10.1210\/endocr\/bqac164","volume":"163","author":"E Stener-Victorin","year":"2022","unstructured":"Stener-Victorin E. Update on animal models of polycystic ovary syndrome. Endocrinology. 2022;163(12):bqac164.","journal-title":"Endocrinology"},{"issue":"8","key":"1299_CR9","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1210\/en.2014-1196","volume":"155","author":"ASL Caldwell","year":"2014","unstructured":"Caldwell ASL, Middleton LJ, Jimenez M, et al. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology. 2014;155(8):3146\u201359.","journal-title":"Endocrinology"},{"issue":"8","key":"1299_CR10","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1210\/en.2007-0168","volume":"148","author":"L Manner\u00e5s","year":"2007","unstructured":"Manner\u00e5s L, Cajander S, Holm\u00e4ng A, et al. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology. 2007;148(8):3781\u201391.","journal-title":"Endocrinology"},{"issue":"1","key":"1299_CR11","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41467-021-21308-y","volume":"12","author":"C Bourgneuf","year":"2021","unstructured":"Bourgneuf C, Bailb\u00e9 D, Lamazi\u00e8re A, et al. The Goto-Kakizaki rat is a spontaneous prototypical rodent model of polycystic ovary syndrome. Nat Commun. 2021;12(1):1064.","journal-title":"Nat Commun"},{"issue":"2","key":"1299_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1677\/joe.1.06264","volume":"187","author":"F Labrie","year":"2005","unstructured":"Labrie F, Luu-The V, B\u00e9langer A, et al. Is dehydroepiandrosterone a hormone? J Endocrinol. 2005;187(2):169\u201396.","journal-title":"J Endocrinol"},{"issue":"1","key":"1299_CR13","first-page":"41","volume":"24","author":"OT Olaniyan","year":"2020","unstructured":"Olaniyan OT, Bamidele O, Uche S, et al. Ovarian metabolic activity in dehydroepiandrosterone-induced polycystic ovary in wistar rats treated with aspirin. JBRA Assist Reprod. 2020;24(1):41\u201354.","journal-title":"JBRA Assist Reprod"},{"issue":"4","key":"1299_CR14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/mrd.23111","volume":"86","author":"Q Shen","year":"2019","unstructured":"Shen Q, Bi H, Yu F, et al. Nontargeted metabolomic analysis of skeletal muscle in a dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome. Mol Reprod Dev. 2019;86(4):370\u20138.","journal-title":"Mol Reprod Dev"},{"issue":"1","key":"1299_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13048-020-00650-7","volume":"13","author":"G Wu","year":"2020","unstructured":"Wu G, Hu X, Ding J, Yang J. The effect of glutamine on dehydroepiandrosterone-induced polycystic ovary syndrome rats. J Ovarian Res. 2020;13(1):57.","journal-title":"J Ovarian Res"},{"issue":"4","key":"1299_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1159\/000518040","volume":"86","author":"HR Shen","year":"2021","unstructured":"Shen HR, Xu X, Ye D, Li XL. Berberine improves the symptoms of DHEA-Induced PCOS rats by regulating gut microbiotas and metabolites. Gynecol Obstet Invest. 2021;86(4):388\u201397.","journal-title":"Gynecol Obstet Invest"},{"issue":"11","key":"1299_CR17","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1093\/humrep\/det341","volume":"28","author":"X Zhang","year":"2013","unstructured":"Zhang X, Zhang C, Shen S, et al. Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats. Hum Reprod. 2013;28(11):3074\u201385.","journal-title":"Hum Reprod"},{"issue":"1","key":"1299_CR18","doi-asserted-by":"publisher","first-page":"38134","DOI":"10.1038\/srep38134","volume":"6","author":"SY Li","year":"2016","unstructured":"Li SY, Song Z, Song MJ, Qin JW, Zhao ML, Yang ZM. Impaired receptivity and decidualization in DHEA-induced PCOS mice. Sci Rep. 2016;6(1):38134.","journal-title":"Sci Rep"},{"issue":"1","key":"1299_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12958-018-0418-y","volume":"16","author":"L Dou","year":"2018","unstructured":"Dou L, Zheng Y, Li L, et al. The effect of cinnamon on polycystic ovary syndrome in a mouse model. Reprod Biol Endocrinol. 2018;16(1):99.","journal-title":"Reprod Biol Endocrinol"},{"issue":"5","key":"1299_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1095\/biolreprod.111.097808","volume":"86","author":"KA Walters","year":"2012","unstructured":"Walters KA, Allan CM, Handelsman DJ. Rodent models for human polycystic ovary syndrome. Biol Reprod. 2012;86(5):1\u201312.","journal-title":"Biol Reprod"},{"issue":"2","key":"1299_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/rmb2.12262","volume":"18","author":"S Osuka","year":"2019","unstructured":"Osuka S, Nakanishi N, Murase T, et al. Animal models of polycystic ovary syndrome: A review of hormone-induced rodent models focused on hypothalamus-pituitary-ovary axis and neuropeptides. Reprod Med Biol. 2019;18(2):151\u201360.","journal-title":"Reprod Med Biol"},{"issue":"5","key":"1299_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1095\/biolreprod.114.120063","volume":"91","author":"H Lai","year":"2014","unstructured":"Lai H, Jia X, Yu Q, et al. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome1. Biol Reprod. 2014;91(5):1\u201311.","journal-title":"Biol Reprod"},{"issue":"2","key":"1299_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/jc.2003-031122","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004;89(2):453\u201362.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1299_CR24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456\u201388.","journal-title":"Fertil Steril"},{"issue":"9","key":"1299_CR25","doi-asserted-by":"publisher","first-page":"bqac097","DOI":"10.1210\/endocr\/bqac097","volume":"163","author":"PS Poojary","year":"2022","unstructured":"Poojary PS, Nayak G, Panchanan G, et al. Distinctions in pcos induced by letrozole Vs dehydroepiandrosterone with high-fat diet in mouse model. Endocrinology. 2022;163(9):bqac097.","journal-title":"Endocrinology"},{"issue":"6","key":"1299_CR26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","volume":"22","author":"AH Balen","year":"2016","unstructured":"Balen AH, Morley LC, Misso M, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687\u2013708.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"1299_CR27","first-page":"314","volume":"43","author":"G Boutzios","year":"2013","unstructured":"Boutzios G, Karalaki M, Zapanti E. Common pathophysiological mechanisms involved in luteal phase deficiency and polycystic ovary syndrome. Impact Ferti Endocrine. 2013;43(2):314\u20137.","journal-title":"Impact Ferti Endocrine"},{"issue":"3","key":"1299_CR28","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.metabol.2003.10.005","volume":"53","author":"M Salehi","year":"2004","unstructured":"Salehi M, Bravo-Vera R, Sheikh A, Gouller A, Poretsky L. Pathogenesis of polycystic ovary syndrome: what is the role of obesity? Metabolism. 2004;53(3):358\u201376.","journal-title":"Metabolism"},{"issue":"5","key":"1299_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.18632\/aging.100327","volume":"3","author":"EP Weiss","year":"2011","unstructured":"Weiss EP, Villareal DT, Fontana L, Han DH, Holloszy JO. Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans. Aging. 2011;3(5):533\u201342.","journal-title":"Aging"},{"key":"1299_CR30","doi-asserted-by":"crossref","unstructured":"Tchernof A, Labrie F. Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur J Endocrinol. Published online July 1, 2004:1\u201314.","DOI":"10.1530\/eje.0.1510001"},{"issue":"S2","key":"1299_CR31","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1038\/sj.ijo.0801280","volume":"24","author":"G De Pergola","year":"2000","unstructured":"De Pergola G. The adipose tissue metabolism: role of testosterone and dehydroepiandrosterone. Int J Obes. 2000;24(S2):S59\u201363.","journal-title":"Int J Obes"},{"key":"1299_CR32","doi-asserted-by":"publisher","first-page":"108710","DOI":"10.1016\/j.steroids.2020.108710","volume":"163","author":"F Wang","year":"2020","unstructured":"Wang F, He Y, Santos HO, Sathian B, Price JC, Diao J. The effects of dehydroepiandrosterone (DHEA) supplementation on body composition and blood pressure: a meta-analysis of randomized clinical trials. Steroids. 2020;163:108710.","journal-title":"Steroids"},{"issue":"6","key":"1299_CR33","first-page":"2198","volume":"81","author":"JC Lovejoy","year":"1996","unstructured":"Lovejoy JC, Bray GA, Bourgeois MO, et al. Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women\u2013a clinical research center study. J Clin Endocrinol Metab. 1996;81(6):2198\u2013203.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1299_CR34","first-page":"2044","volume":"82","author":"JMH Elbers","year":"1997","unstructured":"Elbers JMH, Asscheman H, Seidell JC, Megens JAJ, Gooren LJG. Long-term testosterone administration increases visceral fat in female to male transsexuals1. J Clin Endocrinol Metab. 1997;82(7):2044\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1299_CR35","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/biolre\/ioad004","volume":"108","author":"S Liu","year":"2023","unstructured":"Liu S, Yao Q, Li X, et al. Effects of a ketogenic diet on reproductive and metabolic phenotypes in mice with polycystic ovary syndrome. Biol Reprod. 2023;108(4):597\u2013610.","journal-title":"Biol Reprod"},{"key":"1299_CR36","doi-asserted-by":"publisher","first-page":"e9782373","DOI":"10.1155\/2019\/9782373","volume":"2019","author":"Q Xie","year":"2019","unstructured":"Xie Q, Xiong X, Xiao N, et al. Mesenchymal stem cells alleviate DHEA-induced polycystic ovary syndrome (PCOS) by Inhibiting Inflammation in Mice. Stem Cells Int. 2019;2019:e9782373.","journal-title":"Stem Cells Int"},{"issue":"2","key":"1299_CR37","doi-asserted-by":"publisher","first-page":"e87623","DOI":"10.1371\/journal.pone.0087623","volume":"9","author":"M Jang","year":"2014","unstructured":"Jang M, Lee MJ, Lee JM, et al. Oriental Medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats. PLoS ONE. 2014;9(2):e87623.","journal-title":"PLoS ONE"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01299-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01299-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01299-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T07:37:33Z","timestamp":1700379453000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01299-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1299"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01299-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3046206\/v1","asserted-by":"object"}]},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,25]]},"assertion":[{"value":"10 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal protocols were approved by the Animal Committee of Peking University Health Science Center in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"207"}}